The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Alpelisib and fulvestrant efficacy in HR-positive HER2-negative PIK3CA-mutant advanced breast cancer: Data from the French early access program.
 
Diana Bello
Travel, Accommodations, Expenses - daiichi sankyo; Lilly
 
Alexandre Bertucci
No Relationships to Disclose
 
Thibault De La Motte Rouge
No Relationships to Disclose
 
Cyriac Blonz
No Relationships to Disclose
 
Sarra Akla
No Relationships to Disclose
 
Julien Grenier
Travel, Accommodations, Expenses - AstraZeneca; Eisai Europe
 
Caroline Bailleux
No Relationships to Disclose
 
Marc Antoine Benderra
No Relationships to Disclose
 
Helene Simon
Honoraria - Lilly; Pfizer; Tesaro
Consulting or Advisory Role - Lilly; Mundipharma; Mylan; Novartis; Pierre Fabre; Roche; Sandoz; Vifor Pharma
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Mundipharma; Novartis; Pfizer; Roche
 
Isabelle Desmoulins
No Relationships to Disclose
 
Zoé Tharin
No Relationships to Disclose
 
Emmanuelle Renaud
No Relationships to Disclose
 
Suzette Delaloge
Consulting or Advisory Role - AstraZeneca (Inst); Pierre Fabre (Inst)
Research Funding - AstraZeneca (Inst); Exact Sciences (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Marion Bertho
Travel, Accommodations, Expenses - Pfizer
 
Paul H. Cottu
Honoraria - Lilly; NanoString Technologies (Inst); Novartis (Inst); Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Lilly; Pfizer; Roche/Genentech
Research Funding - Novartis (Inst); pfizer (Inst)
Travel, Accommodations, Expenses - pfizer; Roche
 
Anthony Goncalves
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Cascadian Therapeutics (Inst); Lilly (Inst); Merus (Inst); MSD (Inst); Nektar (Inst); Novartis (Inst); Roche (Inst); Roche/Genentech (Inst); Sanofi/Aventis (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Novartis
 
François-Clément Bidard
Consulting or Advisory Role - Archer; Lilly; Novartis; Pfizer; Radius Health; Sanofi
Speakers' Bureau - AstraZeneca; Novartis; Pfizer; Roche
Research Funding - Menarini Silicon Biosystems (Inst); Novartis (Inst); Pfizer (Inst); ProLynx (Inst); Roche (Inst); SERVIER (Inst)
Patents, Royalties, Other Intellectual Property - ctDNA detection techniques (Inst)
Travel, Accommodations, Expenses - Chugai Pharma; Novartis; Pfizer
 
Florence Lerebours
Travel, Accommodations, Expenses - Lilly; Novartis; Pfizer; Pierre Fabre; Roche